RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES
United Kingdom
98919756.1
Filed on 1998-04-09
98919756.1
Filed on 1998-04-09
RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES
Spain
98919756.1
Filed on 1998-04-09
98919756.1
Filed on 1998-04-09
RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES
Italy
98919756.1
Filed on 1998-04-09
98919756.1
Filed on 1998-04-09
RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES
Germany
98919756.1
Filed on 1998-04-09
98919756.1
Filed on 1998-04-09
RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES
France
98919756.1
Filed on 1998-04-09
98919756.1
Filed on 1998-04-09
RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES
Belgium
98919756.1
Filed on 1998-04-09
98919756.1
Filed on 1998-04-09
METHODS FOR TREATING AND PREVENTING FIBROSIS
Ecuador
SP-07-7821
Filed on 2006-04-13
SP-07-7821
Filed on 2006-04-13
A PHARMACEUTICAL COMPOSITION FOR TREATING AND PREVENTING FIBROSIS BY IL-21/IL-21R ANTAGONISTS
Vietnam
1-2007-02418
Filed on 2006-04-13
1-2007-02418
Filed on 2006-04-13
METHODS FOR TREATING AND PREVENTING FIBROSIS BY IL-21/IL-21R ANTAGONISTS
India
7772/DELNP/2007
Filed on 2006-04-13
7772/DELNP/2007
Filed on 2006-04-13